Contribute
España
Italia
대한민국
日本
Français

Benzinga

Research
My Stocks
Tools
Free Benzinga Pro Trial
SPY
767.000.17%
QQQ
714.250.11%
BTC/USD
77320.630.521%
DIA
532.330.02%
GLD
423.090.06%
TLT
82.020.04%

Processa Pharmaceuticals Inc

PCSANASDAQ
Trade with Public
Trade with Public
$2.08
-0.065-3.03%
At close: Aug 21, 5:00 PM EST
$2.20
0.125.77%
After Hours: Aug 21, 5:40 PM EST
OverviewNewsEarnings ForecastEventsPrice TargetsFinancialsSentimentOwnershipCompareStock Report

Processa Pharma Analyst Price Targets

Wall Street analyst price targets and consensus rating for Processa Pharma (PCSA).

Price Target Range — 6 Quarters

Analyst Consensus — 2 Analysts

1Buy
1Hold
Consensus RatingSpeculative Buy# Analysts2Avg. Consensus PT$3Upside to Avg. PT+13.6%

Rating Trend — Last 9 Months

Recent Analyst Actions

View all ratings →
DateFirmAnalystActionRating ChangePrice Target
Sep 2, 2025HC Wainwright & Co.Raghuram SelvarajuPT CutBuy$2→$1
Jun 30, 2025HC Wainwright & Co.Raghuram SelvarajuPT CutBuy$6→$2
More with Benzinga EdgeGet Access

Analyst Ratings News

PRO
HC Wainwright & Co. Maintains Buy on Processa Pharmaceuticals, Lowers Price Target to $1

HC Wainwright & Co. analyst Raghuram Selvaraju maintains Processa Pharmaceuticals (NASDAQ:PCSA) with a Buy and lowers the price target from $2 to $1.
Benzinga Newsdesk

PRO
HC Wainwright & Co. Maintains Buy on Processa Pharmaceuticals, Lowers Price Target to $2

HC Wainwright & Co. analyst Raghuram Selvaraju maintains Processa Pharmaceuticals (NASDAQ:PCSA) with a Buy and lowers the price target from $6 to $2.
Benzinga Newsdesk

PRO
HC Wainwright & Co. Reiterates Buy on Processa Pharma, Maintains $6 Price Target

HC Wainwright & Co. analyst Raghuram Selvaraju reiterates Processa Pharma (NASDAQ:PCSA) with a Buy and maintains $6 price target.
Benzinga Newsdesk

PRO
HC Wainwright & Co. Reiterates Buy on Processa Pharma, Maintains $6 Price Target

HC Wainwright & Co. analyst Raghuram Selvaraju reiterates Processa Pharma (NASDAQ:PCSA) with a Buy and maintains $6 price target.
Benzinga Newsdesk

PRO
HC Wainwright & Co. Reiterates Buy on Processa Pharma, Maintains $6 Price Target

HC Wainwright & Co. analyst Raghuram Selvaraju reiterates Processa Pharma (NASDAQ:PCSA) with a Buy and maintains $6 price target.
Benzinga Newsdesk

PRO
HC Wainwright & Co. Maintains Buy on Processa Pharma, Lowers Price Target to $6

HC Wainwright & Co. analyst Raghuram Selvaraju maintains Processa Pharma (NASDAQ:PCSA) with a Buy and lowers the price target from $8 to $6.
Benzinga Newsdesk

Data & APIs: Benzinga APIs · Stock News API · Analyst Ratings API · Company Logo API

Market data provided by Benzinga APIs

Connect With Us
instagramlinkedinyoutubeblueskymastodon
About Benzinga
Market Resources
Trading Tools & Education
Ring the Bell
© 2026 Benzinga | All Rights Reserved